BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18080019)

  • 1. Leukemic stem cells: from metabolic pathways and signaling to a new concept of drug resistance targeting.
    Styczynski J; Drewa T
    Acta Biochim Pol; 2007; 54(4):717-26. PubMed ID: 18080019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the cancer stem cell population "a player" in multi-drug resistance?
    Drewa T; Styczynski J; Szczepanek J
    Acta Pol Pharm; 2008; 65(4):493-500. PubMed ID: 19051593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia.
    Huntly BJ; Gilliland DG
    Cancer Cell; 2004 Sep; 6(3):199-201. PubMed ID: 15380509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
    Rizo A; Vellenga E; de Haan G; Schuringa JJ
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R210-9. PubMed ID: 16987886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells: never Wnt away from the niche.
    Malanchi I; Huelsken J
    Curr Opin Oncol; 2009 Jan; 21(1):41-6. PubMed ID: 19125017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.
    Malanchi I; Peinado H; Kassen D; Hussenet T; Metzger D; Chambon P; Huber M; Hohl D; Cano A; Birchmeier W; Huelsken J
    Nature; 2008 Apr; 452(7187):650-3. PubMed ID: 18385740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer.
    Simeone DM
    Clin Cancer Res; 2008 Sep; 14(18):5646-8. PubMed ID: 18794070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in cancer stem cells.
    Cho RW; Clarke MF
    Curr Opin Genet Dev; 2008 Feb; 18(1):48-53. PubMed ID: 18356041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecules in stem cell self-renewal and differentiation.
    Schugar RC; Robbins PD; Deasy BM
    Gene Ther; 2008 Jan; 15(2):126-35. PubMed ID: 17989703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
    Winquist RJ; Boucher DM; Wood M; Furey BF
    Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia stem cells in drug resistance and metastasis.
    Deng CH; Zhang QP
    Chin Med J (Engl); 2010 Apr; 123(7):954-60. PubMed ID: 20497694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells in radiation resistance.
    Rich JN
    Cancer Res; 2007 Oct; 67(19):8980-4. PubMed ID: 17908997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells.
    Zhao RC; Zhu YS; Shi Y
    Pharmacol Ther; 2008 Jul; 119(1):74-82. PubMed ID: 18562010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
    Bisson I; Prowse DM
    Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis.
    Okamoto OK; Perez JF
    Expert Rev Mol Diagn; 2008 Jul; 8(4):387-93. PubMed ID: 18598221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stem cells in development and cancer.
    Brabletz S; Schmalhofer O; Brabletz T
    J Pathol; 2009 Jan; 217(2):307-17. PubMed ID: 19031475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.